All Stories

  1. Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study

    Article • European Journal of Heart Failure, February 2016, Wiley

    Dr Ken Lee Chin, Professor john j mcmurray